Incomplete Deletion of IL-4Rα by LysMCre Reveals Distinct Subsets of M2 Macrophages Controlling Inflammation and Fibrosis in Chronic Schistosomiasis

PLoS Pathogens

Volumn 10, Issue 9, 2014, Pages

  Vannella, Kevin M ^a   Barron, Luke ^a   Borthwick, Lee A ^a,b   Kindrachuk, Kristen N ^a   Narasimhan, Prakash Babu ^a   Hart, Kevin M ^a   Thompson, Robert W ^a   White, Sandra ^a   Cheever, Allen W ^c   Ramalingam, Thirumalai R ^a   A Wynn, Thomas ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; CD11 ANTIGEN; CD16 ANTIGEN; CD32 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD64 ANTIGEN; CRE RECOMBINASE; CYTOKINE; GAMMA INTERFERON; HYDROXYPROLINE; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA; LIVER ENZYME; MESSENGER RNA; STAT6 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL POPULATION; CONTROLLED STUDY; DNA ISOLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSIS; FLOW CYTOMETER; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; INFLAMMATION; LEUKOCYTE; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

EID: 84907588596     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004372     Document Type: Article

References (39)

1. Mosser DM, Edwards JP, (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958–969.
2. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, et al. (2014) Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines. Immunity 41: 14–20.
3. Gordon S, (2003) Alternative activation of macrophages. Nat Rev Immunol 3: 23–35.
4. Wynn TA, (2004) Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 4: 583–594.
5. Duffield JS, Lupher M, Thannickal VJ, Wynn TA, (2013) Host responses in tissue repair and fibrosis. Annu Rev Pathol 8: 241–276.
6. Allen JE, Wynn TA, (2011) Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS Pathog 7: e1002003.
7. Herbert DR, Holscher C, Mohrs M, Arendse B, Schwegmann A, et al. (2004) Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 20: 623–635.
8. Pesce JT, Ramalingam TR, Mentink-Kane MM, Wilson MS, El Kasmi KC, et al. (2009) Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog 5: e1000371.
9. Wynn TA, Barron L, (2010) Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis 30: 245–257.
10. Mentink-Kane MM, Cheever AW, Wilson MS, Madala SK, Beers LM, et al. (2011) Accelerated and progressive and lethal liver fibrosis in mice that lack interleukin (IL)-10, IL-12p40, and IL-13Ralpha2. Gastroenterology 141: 2200–2209.
11. Wilson MS, Elnekave E, Mentink-Kane MM, Hodges MG, Pesce JT, et al. (2007) IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice. J Clin Invest 117: 2941–2951.
12. Barron L, Wynn TA, (2011) Macrophage activation governs schistosomiasis-induced inflammation and fibrosis. Eur J Immunol 41: 2509–2514.
13. Wynn TA, Thompson RW, Cheever AW, Mentink-Kane MM, (2004) Immunopathogenesis of schistosomiasis. Immunol Rev 201: 156–167.
14. Munder M, Eichmann K, Modolell M, (1998) Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J Immunol 160: 5347–5354.
15. Pauleau AL, Rutschman R, Lang R, Pernis A, Watowich SS, et al. (2004) Enhancer-mediated control of macrophage-specific arginase I expression. J Immunol 172: 7565–7573.
16. Mentink-Kane MM, Cheever AW, Thompson RW, Hari DM, Kabatereine NB, et al. (2004) IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis. Proc Natl Acad Sci U S A 101: 586–590.
17. Chiaramonte MG, Donaldson DD, Cheever AW, Wynn TA, (1999) An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest 104: 777–785.
18. Wynn TA, Cheever AW, Jankovic D, Poindexter RW, Caspar P, et al. (1995) An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376: 594–596.
19. Hoffmann KF, Cheever AW, Wynn TA, (2000) IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J Immunol 164: 6406–6416.
20. Chiaramonte MG, Cheever AW, Malley JD, Donaldson DD, Wynn TA, (2001) Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis. Hepatology 34: 273–282.
21. Fallon PG, Richardson EJ, McKenzie GJ, McKenzie AN, (2000) Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol 164: 2585–2591.
22. Martinez FO, Helming L, Gordon S, (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27: 451–483.
23. Dewals BG, Marillier RG, Hoving JC, Leeto M, Schwegmann A, et al. (2010) IL-4Ralpha-independent expression of mannose receptor and Ym1 by macrophages depends on their IL-10 responsiveness. PLoS Negl Trop Dis 4: e689.
24. Jenkins SJ, Ruckerl D, Thomas GD, Hewitson JP, Duncan S, et al. (2013) IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1. J Exp Med 210: 2477–2491.
25. Jenkins SJ, Ruckerl D, Cook PC, Jones LH, Finkelman FD, et al. (2011) Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 332: 1284–1288.
26. Wynn TA, Chawla A, Pollard JW, (2013) Macrophage biology in development, homeostasis and disease. Nature 496: 445–455.
27. Gundra UM, Girgis NM, Ruckerl D, Jenkins S, Ward LN, et al. (2014) Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct. Blood 123: e110–122.
28. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I, (1999) Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 8: 265–277.
29. Hoffmann KF, James SL, Cheever AW, Wynn TA, (1999) Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni. J Immunol 163: 927–938.
30. Hesse M, Modolell M, La Flamme AC, Schito M, Fuentes JM, et al. (2001) Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J Immunol 167: 6533–6544.
31. Herbert DR, Orekov T, Roloson A, Ilies M, Perkins C, et al. (2010) Arginase I suppresses IL-12/IL-23p40-driven intestinal inflammation during acute schistosomiasis. J Immunol 184: 6438–6446.
32. Wynn TA, Cheever AW, Williams ME, Hieny S, Caspar P, et al. (1998) IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease. J Immunol 160: 4473–4480.
33. Chiaramonte MG, Mentink-Kane M, Jacobson BA, Cheever AW, Whitters MJ, et al. (2003) Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response. J Exp Med 197: 687–701.
34. Nieuwenhuizen NE, Kirstein F, Jayakumar J, Emedi B, Hurdayal R, et al. (2012) Allergic airway disease is unaffected by the absence of IL-4Ralpha-dependent alternatively activated macrophages. J Allergy Clin Immunol 130: 743–750 e748.
35. Heredia JE, Mukundan L, Chen FM, Mueller AA, Deo RC, et al. (2013) Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell 153: 376–388.
36. Egawa M, Mukai K, Yoshikawa S, Iki M, Mukaida N, et al. (2013) Inflammatory monocytes recruited to allergic skin acquire an anti-inflammatory M2 phenotype via basophil-derived interleukin-4. Immunity 38: 570–580.
37. Cheever AW, Williams ME, Wynn TA, Finkelman FD, Seder RA, et al. (1994) Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J Immunol 153: 753–759.
38. Khodoun M, Lewis CC, Yang JQ, Orekov T, Potter C, et al. (2007) Differences in expression, affinity, and function of soluble (s)IL-4Ralpha and sIL-13Ralpha2 suggest opposite effects on allergic responses. J Immunol 179: 6429–6438.
39. Wynn TA, Barron L, Thompson RW, Madala SK, Wilson MS, et al. (2011) Quantitative assessment of macrophage functions in repair and fibrosis. Curr Protoc Immunol Chapter 14: Unit14 22.